Pixxoscan

Product NDC
0407-1066
Requested package NDC
0407-1066-02
11-digit product format
004071066
Labeler code
0407
Product ID
0407-1066_5e45495c-0abc-4b5e-ab94-185d9b971d3c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GADOBUTROL
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
GE Healthcare Inc.
Application
ANDA215957
Marketing category
ANDA
Marketing start
2026-09-30
Substance
GADOBUTROL
Active strength
604.72 mg/mL
Pharmacologic classes
Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215957-001PIXXOSCANGADOBUTROL1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29
A215957-002PIXXOSCANGADOBUTROL4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29
A215957-003PIXXOSCANGADOBUTROL6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29
A215957-004PIXXOSCANGADOBUTROL9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A215957-001AP
A215957-002AP
A215957-003AP
A215957-004AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A215957-001PIXXOSCAN1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-002PIXXOSCAN4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-003PIXXOSCAN6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-004PIXXOSCAN9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29d4dbc9d85df4…
2026-10-15 13:18:302026-09A215957-001PIXXOSCAN1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29c2088c7a36db…
2026-10-15 13:18:302026-09A215957-002PIXXOSCAN4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29c2088c7a36db…
2026-10-15 13:18:302026-09A215957-003PIXXOSCAN6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29c2088c7a36db…
2026-10-15 13:18:302026-09A215957-004PIXXOSCAN9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29c2088c7a36db…
2026-09-14 22:38:342026-08A215957-001PIXXOSCAN1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-2984e616aacf4f…
2026-09-14 22:38:342026-08A215957-002PIXXOSCAN4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-2984e616aacf4f…
2026-09-14 22:38:342026-08A215957-003PIXXOSCAN6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-2984e616aacf4f…
2026-09-14 22:38:342026-08A215957-004PIXXOSCAN9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-2984e616aacf4f…
2026-08-18 06:07:402026-07A215957-001PIXXOSCAN1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-002PIXXOSCAN4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-003PIXXOSCAN6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-004PIXXOSCAN9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-001PIXXOSCAN1.20944GM/2ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-002PIXXOSCAN4.5354GM/7.5ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-003PIXXOSCAN6.0472GM/10ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-004PIXXOSCAN9.0708GM/15ML (604.72MG/ML)SOLUTION / INTRAVENOUSAP2026-06-29a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A215957-001AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-002AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-003AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10A215957-004AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09A215957-001AP1c2088c7a36db…
2026-10-15 13:18:302026-09A215957-002AP1c2088c7a36db…
2026-10-15 13:18:302026-09A215957-003AP1c2088c7a36db…
2026-10-15 13:18:302026-09A215957-004AP1c2088c7a36db…
2026-09-14 22:38:342026-08A215957-001AP184e616aacf4f…
2026-09-14 22:38:342026-08A215957-002AP184e616aacf4f…
2026-09-14 22:38:342026-08A215957-003AP184e616aacf4f…
2026-09-14 22:38:342026-08A215957-004AP184e616aacf4f…
2026-08-18 06:07:402026-07A215957-001AP1caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-002AP1caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-003AP1caaa826d4ba7…
2026-08-18 06:07:402026-07A215957-004AP1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-002AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-003AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A215957-004AP1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Pixxoscan
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GADOBUTROL604.72 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1BJ477IO2LInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2fa7e463-c44e-49c7-8c47-021962a5501fAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PixxoscanGADOBUTROLGE Healthcare Inc.2fa7e463-c44e-49c7-8c47-021962a5501f2026-10-09Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215957
application number: ANDA215957
ndc (package): 0407-1066-02
ndc (product): 0407-1066
ndc11 (package): 00407106602

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0407-1066-020040710660210 VIAL, GLASS in 1 BOX (0407-1066-02) / 2 mL in 1 VIAL, GLASS2026-09-30NoNoCurrent